Liquidia Corp cotiza a 26.81 USD y tiene una capitalización bursátil de $2.4B. En los últimos 12 meses ha facturado $451M con un margen de flujo de caja libre del -25.3%. Cotiza a 15.8 veces su flujo de caja libre (P/FCF) y a un PER de 17.2. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hyperte…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $0.74 | $0.52 | $0.15 |
| Estimado | $0.82 | $0.85 | $0.40 | $0.33 |
| Sorpresa | — | -12.9% | +30.0% | -54.5% |
| Métrica | LQDA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -32.5% | -38.6% | +6.2% |
| Net Margin | -43.5% | -33.6% | -10.0% |
| FCF Margin | -25.3% | -13.9% | -11.4% |
| ROE | -154.0% | -40.4% | -113.6% |
| ROA | -21.0% | -32.0% | +11.0% |
| Current Ratio | 2.01 | 2.84 | -0.83 |
| Debt / Equity | — | 0.28 | — |